{{Rsnum
|rsid=9674559
|Gene=RPTOR
|Chromosome=17
|position=80741808
|Orientation=plus
|GMAF=0.2029
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=RPTOR
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 56.6 | 37.2 | 6.2
| HCB | 65.0 | 31.4 | 3.6
| JPT | 69.9 | 28.3 | 1.8
| YRI | 55.8 | 40.1 | 4.1
| ASW | 64.9 | 33.3 | 1.8
| CHB | 65.0 | 31.4 | 3.6
| CHD | 69.4 | 27.8 | 2.8
| GIH | 54.5 | 40.6 | 5.0
| LWK | 56.4 | 37.3 | 6.4
| MEX | 77.6 | 22.4 | 0.0
| MKK | 55.8 | 39.7 | 4.5
| TSI | 61.8 | 34.3 | 3.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=19875696
|Title=Genetic variations in PI3K-AKT-mTOR pathway and bladder cancer risk
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}